Editor
Kotak Alternate Asset Managers (Kotak Alt), a part of the Kotak Mahindra Group, has invested Rs 1,445 crore in Matrix Pharma for its acquisition of US-based pharmaceutical major Viatris’ API business.
This transaction was executed through Kotak Strategic Situations Fund II.
This acquisition will make Matrix the second-largest Indian active pharmaceutical ingredients (API)…
